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ABSTRACT 
Osteoarthritis is a chronic disease 
characterised by the loss of articular cartilage in 
synovial joints through a process of extracellular 
matrix destruction that is strongly associated with 
inflammatory stimuli. Chondrocytes undergo 
changes to their protein translational capacity 
during osteoarthritis, but a study of how disease-
relevant signals affect chondrocyte protein 
translation at the transcriptomic level has not 
previously been performed. In this study we 
describe how the inflammatory cytokine 
interleukin 1-beta (IL-1β) rapidly affects protein 
translation in the chondrocytic cell line SW1353. 
Using ribosome profiling we demonstrate that IL-
1β induced altered translation of inflammatory-
associated transcripts such as NFKB1, TNFAIP2, 
MMP13, CCL2 and CCL7, as well as a number 
of ribosome-associated transcripts, through 
differential translation and the use of multiple 
open reading frames. Proteomic analysis of the 
cellular layer and the conditioned media of these 
cells identified changes in a number of the 
proteins which were differentially translated. 
Translationally-regulated secreted proteins 
included a number of chemokines and cytokines, 
underlining the rapid, translationally-mediated 
inflammatory cascade that is initiated by IL-1β. 
Although fewer cellular proteins were found to be 
regulated in both ribosome profiling and 
proteomic datasets, we did find increased levels 
of SOD2, indicative of redox changes within 
SW1353 cells being modulated at the 
translational level. In conclusion, we have 
produced combined ribosome profiling and 
proteomic datasets which provide a valuable 
resource in understanding the processes that are 
occurring during cytokine stimulation of 
chondrocytic cells. 
 
 
Osteoarthritis (OA) is a chronic disease 
characterised by the loss of articular cartilage in 
synovial joints through a process of extracellular 
matrix (ECM) destruction, driven by extracellular 
proteases (1,2). The disease is multifactorial and 
risk factors include age, genetic predisposition, 
prior trauma and obesity (3-5). Once considered 
to be driven primarily by mechanical processes, it 
is becoming apparent that there is a significant 
role for inflammation in the pathophysiology of 
the disease (6,7). The expression of inflammatory 
cytokines such as interleukin 1-beta (IL-1β) and 
tumour necrosis factor-alpha (TNF-α) caused by 
excessive mechanical loading and trauma can 
contribute to the onset of inflammation and 
alterations to the articular cartilage due to the 
promoted actions of catabolic proteases, such as 
members of the matrix metalloproteinase (MMP) 
family (8-11). Cytokines are also able to induce 
catabolic gene expression in chondrocyte cell 
lines in vitro, mimicking many of the processes 
that occur in chondrocytes during OA 
development, making them valuable model 
systems for determining disease mechanisms 
(12,13). The stable phenotype of a cell line for 
these in vitro studies makes it particularly useful 
for techniques where large numbers of cells are 
required, which would be limited by the use of 
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primary cells. However, when interpreting data 
from these studies it is important that we focus 
our interpretation on processes where the cell line 
best reflects primary cell function. 
Changes in the steady state levels of a 
transcript and its translation rate are not always 
well correlated (14-17). For some time, studies 
focussing on specific genes have provided 
evidence for this and more recently, advances in 
ribosome footprinting approaches has confirmed 
this disassociation (18-21). Marker gene 
expression is often used as a proxy for functional 
phenotype in disease studies and has led to a 
significant increase in our understanding of how 
regulators of disease control the transcriptional 
landscapes. Although the steady state mRNA 
levels measured in transcriptomic studies provide 
important information on the modulation of 
cellular phenotype under different conditions, 
they fail to fully inform us about the dynamic 
post-transcriptional control of mRNA turnover 
and translation. Such processes represent a vital 
tier of phenotypic regulation and contribute 
substantially to the overall functional landscape 
of the cell. 
A number of informative studies have 
described transcriptomic profiling of cells from 
healthy and diseased cartilage (22-25), as well as 
in cell-based models of chondrocyte 
inflammatory responses (26,27). More recently, 
our group has demonstrated transcriptome-wide 
differences in the rates of mRNA decay in 
chondrocytes from normal and osteoarthritic 
tissue (24), and have also shown how post-
transcriptional regulation via RNA binding 
proteins affects both anabolic and catabolic gene 
expression in human chondrocytes (28). These 
studies coincide with the emerging role for 
microRNAs in chondrocyte biology, with links 
between post-transcriptional control of key 
cartilage degrading proteinases in animal models, 
human disease and ageing (29-32). Although it is 
still unclear to what extent discrete control of 
mRNA translation is involved in the processes 
that drive OA, there is emerging evidence which 
suggests that global translation is significantly 
altered by the disease (33). 
Ribosomal profiling is an exciting 
methodology that utilises RNA sequencing 
technology to analyse the ribosomal footprints of 
cellular mRNAs, providing transcriptome-wide 
resolution of active translation within a cell at a 
given time. This technique has already led to a 
number of fresh insights into the mechanisms 
underlying translation across species, as well as 
identifying previously unrecognised protein 
isoforms (34-37). A current requirement for this 
technique is the relatively large starting quantity 
of RNA required per sample as only 5-20% of 
input RNA is recovered after the ribosomal RNA 
removal step, making analysis of many primary 
tissue sources extremely challenging. Therefore, 
in this study we have chosen to use ribosomal 
profiling and proteomic approaches to examine 
how translation is altered in an in vitro model of 
chondrocyte response using the SW1353 
chondrosarcoma line stimulated with the 
inflammatory cytokine IL-1β. By examining total 
mRNA levels, ribosome protected mRNA levels 
and by performing parallel proteomic analysis, 
we provide new understanding of how IL-1β 
regulates genes, as well as identify specific 
groups of mRNAs where translational and 
transcriptional level do not necessarily correlate. 
 
RESULTS 
 
Ribosome protected mRNA suitable for RNA-
Seq analysis can be isolated from SW1353 cells. 
To determine how IL-1β affected 
translation rates we performed ribosome 
profiling analysis on SW1353 cells exposed to 
the cytokine for 3 hours. Total and ribosome-
protected RNA from IL-1β-treated SW1353 cell 
cultures was isolated and processed for RNA-
Seq analysis (Figure 1A; extended workflow 
shown in Supporting Information Figure S1). 
Bioanalyser analysis of RNA-Seq libraries 
showed amplicons with the expected size 
distributions for each sample (Supporting 
Information Table S3). Following sequencing, 
reads were processed and then aligned to the 
human genome before differential translation 
analysis was performed using the riboSeqR 
code via the web-based RiboGalaxy interface. 
A detailed breakdown of all RiboGalaxy 
parameters is shown in Supporting Information 
Table S4. Analysis of triplet periodicity in the 
ribosomal profiled samples demonstrated that 
the reads were mostly 28mers with enrichment 
for those in frame 1, indicating that those reads 
were in frame with the coded protein. (Figure 
1B). Metagene analysis using the plotCDS 
function confirmed that the 28mer reads were 
predominantly frame 1 and demonstrated that 
they were evenly aligned at both the start and 
end of protein coding regions, with a peak in 
reads at the translation start site and a small 
decrease in reads towards the stop codons 
(Figure 1C). 
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Ribosome profiling demonstrates that IL-1β-
induced inflammatory secretory proteins in 
SW1353 cells are differentially translated. 
Differential translation analysis of 
ribosome protected fragments (RPFs) was 
performed using the baySeq (38) function via 
RiboGalaxy and revealed that the majority of the 
statistically significant (q<0.001) top 200 
transcripts differentially translated following IL-
1β stimulation were increased compared to 
untreated (Supporting Information Stable S5). 
Once duplicate transcripts were excluded, there 
were 112 transcripts for individual proteins. Only 
four transcripts translated at a lower rate: 
ZC3H12A, two serine/threonine kinase PIM1 
transcripts and one of two transcript variants for 
TNFAIP2. The majority of the differentially 
translated transcripts identified as linear mRNA 
transcripts (93% of transcripts), with the 
remaining identified as non-coding RNAs or 
pseudogenes (7% of transcripts; Supporting 
Information Table S5). STRING analysis of the 
top 200 differentially translated transcripts 
identified via ribosome profiling demonstrates 
that a large proportion coded for either 
inflammatory-associated proteins (Figure 2A, 
blue circle; 37 transcripts; 18.5%) or ribosomal-
associated proteins (Figure 2A, red circle; 63 
transcripts; 31.5%). Interestingly, STRING-
derived protein networks from the top 200 
statistically significant (q<0.05) proteins 
identified in the secretome data showed similar 
groupings (Figure 2B). STRING analysis of the 
42 proteins significantly differentially regulated 
(q<0.05) in the cellular proteomic analysis 
identified a cluster of interferon-associated 
proteins regulated 24 hours after IL-1β 
stimulation (Figure 2C, grey circle). 
Commonality between these significantly 
regulated transcripts/proteins identified by 
ribosome profiling, cellular proteomic analysis 
and secretome analysis is illustrated in Figure 2D. 
A number of proteins that were observed to be 
differentially translated after 3 hour exposure to 
IL-1β also exhibited alterations in their absolute 
level after 24 hours exposure, with examples 
observed in both the cellular proteome (IFIT2/3 
ISG15 and SLC39A14) and in the secretome 
(CCL2, CCL7, CCL8, , IL6, MMP13, PKM and 
RPL13,). Taken together, our data suggests that a 
proportion of the inflammatory response of 
SW1353 cells to IL-1β treatment occurs as a 
result of the rapid increase in the translation rates 
of chemokines, cytokines and associated 
secretory proteins. 
In follow up to this, the levels of CCL2 
and IL-6 (both of which showed increased levels 
of translation and protein secretion in response to 
IL-1β exposure were measured by ELISA in the 
media of either SW1353 cells or primary human 
articular chondrocytes (HACs) exposed to 
different doses of IL-1β for 24 hours or for 
different times following stimulation with 
10ng/ml IL-1β (Figure 3). Interestingly, the 
primary cells were more responsive to lower 
doses of IL-1β. This was particularly striking in 
the CCL2 data where the lowest concentration of 
IL-1β (0.1ng/ml, Figure 3B) was able to elicit a 
significant increase in CCL2 secretion, whereas 
SW1353 secretion only increased at 5ng/ml and 
above (Figure 3A). A similar result was found for 
the IL-6 data (Figure 3E and F), although variance 
of donor response for the primary chondrocytes 
precludes statistical confirmation of this with the 
current sample size. For both CCL2 and IL6, the 
SW1353 cells (Figure 3C and G) and the primary 
chondrocytes (Figure D and H) exhibited similar 
longitudinal secretory responses to 10ng/ml IL-
1β, the experimental concentration used in Ribo-
Seq and proteomic parts of the study.  
 
IL-1β induces altered translation of 
inflammatory-associated transcripts and 
translation via multiple open reading frames. 
We examined Ribo-Seq and total RNA-
Seq reads for differentially translated genes. 
Reads from each reading frame (measured 
against left hand y-axis) were plotted on top of 
total RNA-Sequencing reads (plotted against 
right hand y-axis) using the RiboGalaxy 
platform (Figure 4). The x-axis of these charts 
represents the entire length of the particular 
transcript with the coding domain sequence 
indicated. Some of the differentially translated 
transcripts examined, e.g. NKFB1 (Figure 4A) 
and TNFAIP2 (Figure 4B), exhibited an 
increase in both the total RNA counts and ribo-
counts, suggesting and increase in both 
transcription and translation. Interestingly, 
some of the differentially translated transcripts 
exhibited a marked reduction in total RNA 
reads whilst simultaneously showing an 
increase in RPF reads, indicating reduced 
transcription rates and/or increased rates of 
turnover alongside an increased rate of 
translation. Examples of this were found for the 
chemokines CCL2 and CCL7 (Figure 4C and 
D) and the NFkB signalling component 
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NFKB1Z (Figure 4E). We also observed 
clustered ribosome protected reads outside of 
the normal transcript protein coding sequence 
(CDS), within discrete regions of the 3’UTR, 
for a limited set of genes. Examples of these 
were reads observed in the 3’UTR for TNFAIP2 
(Figure 4B) and for SOX9 (Figure 4F) 
(although note that SOX9 was only in the top 
200 of differentially translated transcripts when 
all three reading frames were examined together 
and not when focusing on frame 1 from the 
triplet periodicity data). For SOX9, the increase 
in ribo-counts came mostly from regions within 
the SOX9 3’UTR, suggesting that translation of 
SOX9 was not increased but instead, there was 
an increase in ribosome occupation or 
interaction at this region in response to IL-1β 
stimulation.  
Despite the triplet periodicity and 
metagene analysis of 28mer RPFs showing that 
the majority of transcripts were from protein 
coding regions within frame 1 (Figure 1B and 
1C), individual riboplots for some transcripts that 
were identified as being differentially translated 
show that transcripts were being translated from 
more than one open reading frame (ORF). For 
example, the riboplot for CCL2 (Figure 4C) 
shows that after IL-1β treatment there was an 
increase in CCL2 ribo-counts in frame 2 and 
frame 3. Whereas for CCL7 (Figure 4D), the 
majority of ribo-counts increased after IL-1β 
treatment were from frame 1, with just a couple 
from frames 2 and 3. Taken together, these results 
suggest that while the number of mRNA 
transcripts may increase or decrease in response 
to IL-1β treatment, rates of active mRNA 
translation do not necessarily reflect changes in 
transcription. 
   
IL-1β induces redox changes in SW1353 cells. 
Results from the SW1353 cellular 
proteomic data showed that SOD2 was one of the 
highest ranked, differentially expressed proteins 
following exposure to IL-1β (Supporting 
Information Table S1). When ribosome profiling 
data from all three frames was analysed, SOD2 
was identified as one of the most highly 
differentially translated transcripts The riboplot 
for SOD2 (Figure 5A) showed that SOD2 reads 
were predominantly in frame 3 and of all the 
transcripts examined, show the largest increase in 
ribo-counts following IL-1β treatment (from 55 to 
1509). Total RNA read coverage for SOD2 
remained largely unchanged however, strongly 
suggesting that IL-1β significantly increases 
SOD2 levels at the translational level. Western 
blotting of cellular lysates from IL-1β (10 ng/ml) 
treated SW1353 showed that this increase in 
translation also resulted in an increase in protein 
expression in a time-dependent manner when 
(Figure 5B, left panel). After 24 hours of IL-1β 
stimulation at a range of IL-1β concentrations, 
SOD2 levels were also increased (Figure 5B, 
right panel). However, it is currently unknown at 
what timeframe this SOD2 expression took place.  
To further investigate the possibility that 
IL-1β treatment causes redox changes, ROS 
detection assays were carried out. Results show 
that with 10 ng/ml IL-1β treatment, there is a 
significant level of variance of ROS activity over 
time (Figure 5C, left panel). IL-1β treatment 
appears to quickly induce levels of ROS, which 
then reduce with time in correlation to SOD2 
protein expression via western blotting (left 
panels of Figures 5B and C). Concentrations of 
IL-1β  as low as 0.1ng/ml resulted in an increase 
in ROS activity (Figure 5C, right panel) but still 
induced SOD2 at similar levels to 10 ng/ml dose 
after 24 hours. This data, along with the increase 
in NFKB1 mRNA expression and translation 
(Figure 4A) suggest that IL-1β treatment activates 
NFκB and a cellular stress response within the 
SW1353 cells, which is controlled through 
translational mechanisms.  
 
DISCUSSION 
In order to study how IL-1β alters 
translation using ribosome profiling, a suitable 
model system was required which maintained 
biologically relevant aspects of cell function with 
the practical requirements of obtaining relatively 
large quantities of total RNA. The number of cells 
required for ribosome profiling made the use of 
freshly isolated primary chondrocytes unfeasible, 
whilst expansion of these cells results in a 
progressive loss of phenotype that quickly leads 
to them sharing the majority of their 
transcriptomic signature with cultured cells from 
connective tissues such as tendon (39). We were 
therefore attracted to the use of a chondrocytic 
cell line that exhibited similar responsiveness to 
IL-1β as primary chondrocytes. Gebauer et al. 
(13) found that the SW1353 chondrosarcoma cell 
line displayed considerably reduced expression of 
ECM components, but were still a valuable 
system for investigating catabolic gene regulation 
by IL-1β. In line with this, our data has shown 
there is an increase in IL-1β, IL-6, LIF, NFKB1 
and TNFAIP6 mRNA expression following IL-
1β stimulation (Supporting Information Table S5) 
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which replicates that observed in IL-1β-treated 
HAC by Gebauer et al. (13). There are always 
limitations to accept with such cell lines, of 
course and there is evidence that SW1353 and 
another chondrocyte cell line, T/C-28a2, do not 
regulate inducible nitric oxide synthase 
expression in the same way as HACs following 
stimulation with pro-inflammatory cytokines 
(40). However, in this instance, we decided to use 
the SW1353 cell line as an in vitro replacement 
for HACs.  
We believe that this is the first time that 
ribosome profiling has been used to study a 
chondrocytic cell type. Ribosome protected 
fragments were detected from 26 – 30 nucleotides 
in length, with the majority being 28mers (Figure 
1B). Metagene analysis with our ribosome 
profiling data showed that most RPFs were found 
relatively evenly across protein coding regions, as 
expected. However, there were instances where 
RPFs were found within the 3’UTR, such as in 
TNFAIP2 (Figure 4B) and SOX9 (Figure 4F). 
Miettinen and Bjorklund (41) suggest that this 
association of ribosomes with the 3’UTR could be 
due to migration of the ribosome through the stop 
codon, or the 3’UTR folding round on itself and 
associating with ribosomes on the CDS. 
Therefore, the potential for interactions with 
ribosomes and the 3’UTR of these mRNAs 
suggest a role in translational regulation. Given 
the well-established role of these two proteins in 
cartilage biology, this may represent an 
interesting new regulatory mechanism controlling 
cartilage function.  
Whilst it appears from our 
complementary proteomic and ribosome profiling 
data that IL-1β treatment results in an up-
regulation of ribosomal-associated transcripts and 
transcripts for inflammatory mediators, the 
presence of ribosomal-associated proteins in the 
SW1353 secretome at first seemed unusual. 
However, the source of ribosomal-associated 
proteins in the media samples could be due to the 
presence of exosomes, which are constantly 
secreted by all cells in culture. Exosomes are 
small vesicles (30-150 nm) containing up to 
thousands of proteins and small RNAs and they 
have a variety of functions such as facilitation of 
the immune response, antigen presentation, 
programmed cell death and inflammation (42). 
Exosomes are also a novel mechanism for cell-to-
cell communication (43). Another possibility for 
the source of ribosomal-associated proteins in the 
cell culture media is due to cell lysis at the point 
of media harvesting and the presence of Actin and 
other Actin-related proteins (Supporting 
Information Table S2) supports this theory. There 
was also a large proportion of ribosomal-
associated transcripts identified through ribosome 
profiling differential translation analysis. It is not 
clear whether this change is a specific response to 
IL-1β or a general response induced by a potential 
alteration in the translational burden on the cells 
during their response. 
Differential translation analysis in this 
study showed that as well as ribosomal-associated 
and inflammatory mediator-associated transcripts 
being up-regulated in response to IL-1β 
treatment, the expression of 14 pseudogenes, 9 of 
which were pseudogenes for ribosomal proteins, 
were also detected. Ribosomal protein 
pseudogenes represent the largest class of 
pseudogenes within the human genome (44) and 
ribosomal pseudogenes have been detected in 
many human tissues, but their function remains 
unclear (45). Differential translation analysis also 
found that IL-1β treatment decreased the 
translation of only two transcripts; PIM1 and 
ZC3H12A. PIM1 is a proto-oncogene with 
serine/threonine kinase activity involved in cell 
survival, proliferation and apoptosis (46). As 
exogenous IL-1β treatment has been shown to 
both stimulate and inhibit apoptosis in different 
cell systems (47), the decrease in PIM1 
expression seen here could suggest that IL-1β 
treatment could be activating apoptosis in this 
system, although no other apoptotic-associated 
transcripts were detected in the differential 
translation analysis. ZC3H12A is a 
transcriptional activator with endoribonuclease 
activity that is involved in a variety of biological 
functions, including the cellular inflammatory 
response. IL-1β has been shown to up-regulate 
ZC3H12A expression via the NFκB and ERK 
pathways (48), which is contrary to what was 
found in this study. 
The riboplots in Figure 4 show that some 
transcripts, such as NFKB1 and TNFAIP2 
experience an increase in transcript level and 
translation rate following IL-1β exposure, 
whereas other transcripts such as CCL2, CCL7, 
and NFKB1Z experience a simultaneous 
reduction in transcript level with an increase in 
translation. This observation of genes under both 
transcriptional and translational control has also 
been observed by others (49,50) and confirms the 
complexity of gene regulation. Elevation of 
CCL2 and CCL7 in particular represent a primed, 
early response to IL-1β stimulation which is 
likely to be characterised by rapid secretion that 
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will be quickly switched off. The role of the rapid, 
translationally mediated secretion of chemokines 
by chondrocytes may represent an important, 
physiological means of cell to cell signalling in 
healthy tissue and merits further study. 
OA was once considered to be a non-
inflammatory disease, caused by excessive wear 
and tear on the articular cartilage of the affected 
joint. More recently however, it has been 
recognised that inflammation plays a significant 
role in OA pathogenesis (7,8,51). In both diseased 
tissue and in this in vitro model, the onset of 
inflammation by inflammatory cytokines such as 
IL-1β, up-regulates the expression of transcripts 
that code for enzymes such as MMP13, which 
causes further cartilage degradation (52). 
Reactive oxygen species (ROS) and oxidative 
stress have also been shown to play a significant 
role in OA progression (53,54) and through the 
activation of the redox-sensitive NFκB 
transcription factor, chondrocytes increase SOD2 
production to prevent ROS-mediated damage 
(55-57). Across the three areas studied here, 
cellular proteome, secretome and translatome, 
activation of NFκB in response to IL-1β was 
consistent. The increase in SOD2 translation and 
protein expression in this SW1353 model 
suggests IL-1β induces changes in the 
mitochondrial redox balance through 
translational regulation. ROS levels rise rapidly 
upon IL-1β stimulation and drop as production of 
SOD2 rises. However, low levels of IL-1β 
(e.g.01.ng/ml) can lead to increased ROS 
generation at 24-hours despite SOD2 levels 
increasing, suggesting that there is a greater 
complexity to the mechanism of cytokine 
responsive redox control in these cells. 
The mechanisms through which 
chondrocyte translation is regulated has not been 
thoroughly studied. However, two pioneering 
recent recent studies has shown that osteoarthritic 
and cytokine mediated translational changes in 
chondrocytes are mediated by the activity of the 
CAP dependent translation repressor 4E binding 
protein 1 (58), possibly acting downstream of 
mechanistic target of rapamycin complex 1 
signalling (59). In addition, small RNAs that are 
known to regulate translation, such as 
microRNAs and snoRNAs are known to 
differentially expressed in normal and 
osteoarthritic cartilage (60,61). The influences of 
these mechanisms on the translation of many of 
the transcripts identified in this study is clearly 
now warranted. 
In summary, this study shows for the first 
time the use of ribosome profiling in a 
chondrocytic cell, observing the effects of IL-1β 
on translational regulation. We have shown that 
through differential translation IL-1β can induce 
the secretion of inflammatory proteins and 
promote changes in redox regulators in these 
cells. It is possible that chondrocytes are primed 
to rapidly respond to inflammatory cytokine 
stimulation, producing a cascade of further 
inflammatory mediators. Whether there is a role 
for this rapid responsiveness in the maintenance 
tissue homeostasis in healthy tissue remains, for 
now, a key unanswered question.  
 
EXPERIMENTAL PROCEDURES 
Cell culture 
The SW1353 chondrosarcoma cell line 
(ATCC HTB-94) was cultured in Dulbecco’s 
Modified Eagles Medium (DMEM, 
ThermoFisher Scientific, 31885023) containing 
10% Foetal Bovine Serum (FBS, Sigma, F7524), 
100 units/ml penicillin-streptomycin (Gibco, 
15140122) and 5 µg /ml amphotericin B (Gibco, 
15290018), cultured at 37 °C in a 5% CO2 
environment. Osteoarthritic human articular 
cartilage (HAC) was obtained with approval from 
the Cheshire Research Ethics Committee 
following total knee arthroplasty. Primary 
articular chondrocytes  were isolated from 
cartilage tissue using the medium described 
above, supplemented with 0.08% type II 
collagenase (Worthington Biochemical), 
overnight at 37 °C.  Cells were cultured as 
described for SW1353.  
 
Proteomic mass spectrometry and label-free 
quantification  
To determine how protein secretion and 
cellular proteome changes were affected by 
cytokine stimulation, SW1353 cells were 
cultured for  24 hours in the presence or absence 
of 10 ng/ml IL-1β in serum-free, phenol red-free 
DMEM (n=3 for each condition). Media was 
collected from the cells and then subjected to in-
solution trypsin digestion and LC-MS/ MS (see 
below). Protein extracts from the SW135 cell 
layer were prepared were prepared in 50mM 
ammonium bicarbonate containing 25 mM N-
ethylmaleimide (d(0) NEM) pH 8. Protein 
lysates were prepared by centrifugation at 
15,000 xg for 10min at 4 °C. Excess d(0) NEM 
was removed using Zeba desalting columns 
(ThermoFisher Scientific) and protein 
concentrations were determined using Bradford 
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assay (BioRad) with BSA as a standard. 100 µg 
of protein extract was diluted to 160 µl with 25 
mM ammonium bicarbonate and denatured by 
the addition of 10 µl of 1% RapiGest (Waters, 
Manchester, UK) in 25 mM ammonium 
bicarbonate and incubated at 80 °C for 10 min 
with shaking. 10 µl of a 100 mM solution of 
Tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP) was added to reduce reversibly oxidised 
Cys residues followed by incubation at 60 °C 
for 10 min. Newly reduced Cys were then 
alkylated by addition of d(5) NEM and 
incubated at room temperature for 30 min. An 
aliquot of the samples was used at this point to 
check procedure by SDS-PAGE. Proteolytic 
digestion was performed by addition of trypsin 
followed by overnight incubation at 37 °C. 
Digestion was terminated and RapiGest 
removed by acidification (3 µl of TFA and 
incubated at 37 °C for 45min) and 
centrifugation (15,000 xg for 15 min). 
Mass spectrometry was performed 
using an Ultimate 3000 RSLC™ Nano system 
(ThermoFisher Scientific) coupled to a 
QExactive™ mass spectrometer (ThermoFisher 
Scientific). 250 ng per sample were loaded onto 
the trapping column (Thermo Scientific, 
PepMap100, C18, 75 μm X 20 mm), using 
partial loop injection, for seven minutes at a 
flow rate of 4 μL/min with 0.1% (v/v) TFA. The 
sample was resolved on the analytical column 
(Easy-Spray C18 75 µm x 500 mm 2 µm 
column) using a gradient of 97% A (0.1% 
formic acid) 3% B (99.9% ACN 0. 1% formic 
acid) to 60% A 40% B over 120 minutes at a 
flow rate of 300 nL/min. The program used for 
data acquisition consisted of a 70,000 resolution 
full-scan MS scan (AGC set to 106 ions with a 
maximum fill time of 250 ms) the 10 most 
abundant peaks were selected for MS/MS using 
a 17,000 resolution scan (AGC set to 5 X 104 
ions with a maximum fill time of 250 ms) with 
an ion selection window of 3 m/z and a 
normalized collision energy of 30. To avoid 
repeated selection of peptides for MS/MS the 
program used a 30 second dynamic exclusion 
window. 
Label-free relative quantification 
software PEAKS™ 7 (Bioinformatics Solutions 
Inc, Waterloo, Canada) was used to analyse 
RAW data files against the same mouse protein 
database for identifications with Mascot. 
Proteins were considered significantly changed 
between 0 and 24 hour IL-1β-treated samples 
using a -10logP score > 20 (equivalent to a P 
value < 0.01), a fold change > 2 and at least 3 
unique peptides. The full list of identified 
proteins including statistical analysis is 
included in Supporting Information Table S1. 
Protein concentrations of media 
samples from SW1353 cultured for 24 hours in 
the presence or absence of 10 ng/ml IL-1β in 
serum-free, phenol red-free DMEM (n=3 for 
each condition), were estimated by Bradford 
assay using Coomassie Plus™ protein assay 
reagent (ThermoFisher Scientific, 23236) read 
at 600nm.  Prior to trypsin digestion, the protein 
concentration of each sample was calculated 
using the PierceTM 660 nm protein assay 
(ThermoFisher Scientific, 22662).   In-solution 
tryptic digest was carried out on 10 μl of 
StrataClean resins (Agilent Genomics, 400714) 
on 100 μg protein for each sample as previously 
described (62). LC-MS/MS was performed 
using an Ultimate 3000 RSLCTM Nano system 
(ThermoFisher Scientific) coupled to a 
QExactiveTM mass spectrometer (ThermoFisher 
Scientific). Tryptic peptides (250 ng) from 
randomised samples were loaded onto the 
column on a 2 hour gradient with an inter-
sample 30 min blank (63). 
 
Western blotting 
For western blotting homogenised protein 
lysates were diluted using laemmli buffer and 
20 µg of protein separated on 12 % SDS-PAGE 
gels. Proteins were transferred using a semi-dry 
blotter. Membranes were blocked in Odyssey 
blocking buffer in TBS (Licor, 927-50000) and 
then incubated with primary antibody for SOD2 
(Cell Signaling Technology, 13194) at a 
dilution of 1:750 in blocking buffer. IRDye 
800CW Goat anti-rabbit secondary antibody 
(Licor, 925-32210) was diluted 1:10,000 in 
blocking buffer. Antibody signal was detected 
using the Odyssey CLx imaging system (Licor) 
and images were acquired and analysed 
usingthe Image Studio Acquisition software 
(Licor). Total protein staining was carried out 
using InstantBlue Protein Gel Stain (Expedeon, 
ISB1L), then imaged using the ChemiDoc 
XBS+ Molecular Imager (BioRad) and Image 
Lab software (BioRad). 
 
CCL2 and IL-6 ELISAs 
SW1353 and HACs were treated with 0, 0.1, 
0.5, 1, 5 and 10 ng/ml IL-1β for 24 hours, or 
with 10 ng/ml IL-1β for 0, 1, 3, 6, 24 and 48 
hours and medium was harvested for CCL2 
(R&D Systems, DY279) and IL-6 (R&D 
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Systems, DY206) ELISAs. For IL-1β 
concentration-dependent treatment, HAC 
donors M70, M76 and M86 were used. For time 
dependent IL-1β treatment, HAC donors M69, 
F80 and F86 were used. Optical density was 
measured using the SPECTROstar Nano 
spectrophotometer (BMG Labtech) and the 
MARS data analysis software (BMG Labtech). 
Cytokine secretion levels were normalised to 
either 0 ng/ml IL-1β, or 0h treatment. Charts 
were plotted and statistical analysis (ANOVA 
and Dunnett’s multiple comparison test) was 
performed using Prism (GraphPad). Data was 
considered statistically significant if P-value 
was <0.05.  
 
ROS detection assay 
For ROS detection, SW1353 were treated with 
IL-1β (ranging from 0 to 10 ng/ml) for 24 hours, 
or with 10 ng/ml IL-1β for 0, 0.5, 1, 3, 6, 24, 30 
and 48 hours in 96-well plates. H2O2 treatment 
(200 μm for 2 hours) served as a positive control 
for ROS production. ROS detection was carried 
out using CM-H2DCFDA (ThermoFisher 
Scientific, C6827). Fluorescence was measured 
using the SPECTROstar Nano 
spectrophotometer (BMG Labtech) and the 
MARS data analysis software (BMG Labtech). 
Charts were plotted and statistical analysis 
(Dunnett’s multiple comparison test) was 
performed using Prism (GraphPad). Data was 
considered statistically significant if P-value 
was <0.05.  
 
Purifying ribosome protected RNA 
Ribosome profiling was carried out 
similar to the method described by Ingolia et al. 
(64), modified with the use of the ARTseq 
(Mammalian) Ribosome Profiling Kit (Epicentre, 
RPHMR12126). Serum was withdrawn when the 
cells had reached ~80% confluence and then 24 
hours later the cells were treated with 10 ng/ml 
IL-1β (Sigma, I9401) for 3 and 24 hours (3x 
175cm2 flasks per time point, n=3).  
To harvest cells for ribosome profiling, 
cell culture media was removed and cells were 
washed with ice-cold PBS containing 0.1 mg/ml 
cycloheximide (Millipore UK Ltd, 239763). Cells 
were scraped into 800 µl mammalian lysis buffer 
(20% v/v 5x Mammalian Polysome Buffer 
(supplied in ARTseq RP Kit), 1% v/v Triton X-
100 (supplied), 10 mM DTT (supplied), 10 U/µl 
DNase I (supplied), 0.1 mg/ml cycloheximide), 
then passed through a 22-25 G needle to lyse the 
cells completely. Cell lysate was then incubated 
on ice for 10 minutes and then centrifuged for 10 
minutes at 20,000 xg at 4 °C. The supernatant was 
transferred to a pre-chilled tube and kept on ice. 
A 1:10 dilution of the clarified supernatant was 
prepared using nuclease-free water and the A260 
reading of the lysate was determined using a 
nanodrop spectrophotometer.  For each sample, 
the supernatant was split into 100 µl aliquots and 
to one aliquot, 10 µl 10% SDS was added and 
served as the ‘Total RNA’ sample. To the 
remaining 100 µl aliquots, 5 units of ARTseq 
Nuclease was added for each A260 of lysate and 
incubated at room temperature for 45 minutes 
with gentle mixing. Nuclease digest reactions 
were stopped by the addition of 300 U of 
SUPERase•In Inhibitor (ThermoFisher 
Scientific, AM2696). The ribosome protected 
fragments (RPFs) were purified according to the 
ARTseq Ribosome Profiling Kit (Mammalian) 
protocol. Briefly, the 100 µl aliquots that were 
nuclease digested earlier were added to Micro-
Spin S-400 columns (GE Healthcare, 27-5140-
01), which had been equilibrated by gravity flow 
with 3 ml of 1x Mammalian Polysome Buffer and 
centrifuged for two minutes at 600 xg. The flow-
through was collected and 10 µl 10% SDS was 
added – this then served as the ‘Ribosome 
Protected RNA’ (RPF) sample. 
 
RNA purification and ribosome depletion 
Total and RPF RNA samples were 
purified using the TRIzol/chloroform method. 
Ribosomal RNA (rRNA) was depleted from the 
Total and RPF RNA samples using the Ribo-
Zero rRNA Removal Kit (Epicentre, 
RHZ110424). Briefly, 1-5 µg of RNA was 
incubated at 68 °C for 10 minutes with Ribo-
Zero rRNA Removal Solution (supplied) and 
then at room temperature for 15 minutes, before 
mixing with pre-prepared microspheres 
(supplied). Hybridised RNA-microspheres 
were incubated at room temperature with 
frequent mixing for 10 minutes to allow rRNA 
to bind to the microspheres, which were then 
removed by centrifuging the sample at 12,000 
xg in a Microsphere Removal Unit (supplied). 
The filtrate containing the rRNA-depleted RNA 
was then purified using the TRIzol/chloroform 
protocol described above. rRNA-depleted Total 
RNA samples were then heat fragmented (see 
below) and RPF RNA samples were then PAGE 
purified.  
 
Fragment and end repair and 3’Adaptor 
ligation 
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rRNA-depleted Total RNA samples 
were heat fragmented at 94 °C for 20 minutes 
and then held at 4 °C. Both heat fragmented 
Total RNA samples and PAGE purified RPF 
RNA samples were then end repaired using 
ARTseq PNK enzyme, incubating for 1 hour at 
37 °C. RNA samples were then purified using 
the TRIzol/chloroform protocol and eluted into 
10 µl nuclease-free water. RNA samples were 
incubated with the supplied ARTseq 3’Adaptor 
(supplied) for 2 minutes at 65 °C and then held 
at 4 °C. These denatured RNA samples were 
then incubated with the supplied ARTseq 
Ligase (supplied), ligation buffer (supplied) and 
100 mM DTT at 23 °C for 2 hours. The supplied 
ARTseq AR Enzyme (supplied) was then added 
to this ligation mix and incubated at 30 °C for 
30 minutes. RNA samples were then reverse 
transcribed. 
 
cDNA synthesis and circularisation 
The 3’adaptor-ligated RNA samples 
were reverse transcribed using the supplied 
EpiScript Reverse Transcriptase (supplied) at 
50 °C for 30 minutes. Reverse transcription 
samples were then incubated with the supplied 
ARTseq Exonuclease (supplied) at 37 °C for 30 
minutes and then 80 °C for 15 minutes before 
adding the ARTseq RNase mix (supplied) and 
incubating the samples at 55 °C for 5 minutes. 
Samples were then held at 4 °C before PAGE 
purifying the cDNAs on 10% 
polyacrylamide/7-8M urea/TBE gels using 
bromophenol blue at 180 V with SYBR Gold 
(ThermoFisher Scientific, S11494) staining. 
cDNA was circularised using the supplied 
CircLigase (supplied) by incubating for 2 hours 
at 60 °C with the ARTseq CircLigase Reaction 
Mix (supplied), ATP and MnCl2 (both 
supplied), before holding at 4 °C. Circularised 
cDNA was then PCR amplified as described 
below. 
 
PCR amplification 
Circularised cDNA (5 µl) was mixed 
with 2 µl of the ARTseq Forward PCR Primer 
(supplied), 2 µl of a ScriptMiner Index PCR 
primer of choice (supplied index primers 1-12) 
and 25 µl 2x Phusion High-fidelity PCR Master 
Mix (New England Biolabs, M0531) in a total 
volume of 50 µl. Samples were then ran in 
following PCR program: 98 °C for 30 seconds, 
then 15 cycles of 94 °C for 15 seconds, 55 °C 
for 5 seconds and 65 °C for 10 seconds. PCR 
products were purified using the Agencourt 
AMPure XP beads (Beckman Coulter, A63880) 
according to the manufacturer’s instructions 
and eluted into 25 µl nuclease-free water. To 
check for successful PCR amplification, 2.5 µl 
of the PCR amplified samples was mixed with 
6x native gel loading dye and run on a Novex 
8% NativeTBE gel (Thermo Fisher Scientific, 
EC6215BOX) at 200 V until the dye front 
reached the bottom of the gel, with ΦX174 RF 
DNA/HAE III fragments as markers 
(ThermoFisher Scientific, 15611-015). The gel 
was then stained with SYBR Gold and 
visualised using a dark field transilluminator. 
Samples that contained successfully amplified 
libraries (140-160 bp) were sent for QC and 
sequencing. 
 
Quality control and sequencing 
Successfully amplified PCR libraries 
were sent to the University of Liverpool’s 
Centre for Genomic Research for sequencing. 
Samples were quantified using a Qubit dsDNA 
High Sensitivity Kit (Life Technologies, 
Q32854) and a Bioanalyser DNA High 
Sensitivity Kit (Agilent, 5067-4626), using 1 µl 
per sample of a 2 ng/µl dilution of each library. 
Libraries were then pooled at equi-molar 
quantities and the pooled libraries were size 
selected within 120-160 bp on a SAGE 
PippinPrep instrument using a 1.5% agarose gel 
cassette. The size selected pooled library was 
assessed by Bioanalyser and subsequently by 
qPCR using the Illumina Library Quantification 
Kit (KAPA Biosystems, KK4854) on a Roche 
Light Cycler LC480II according to the 
manufacturer’s instructions. The template DNA 
was denatured according to the protocol 
described in the Illumina cBot User Guide and 
loaded a at 12 pM concentration. Sequencing 
was performed using an Illumina HiSeq2500 
with 125 bp reads at the Centre for Genome 
Research at the University of Liverpool. A 
summary of the quality control data can be 
found in supporting information Table S3.   
 
RNA-Seq data analysis 
The total number of reads from each 
sample varied from 7.5 x106 to 5.9 x107. 
FASTQ files containing reads from ribosome 
protected and total RNA sample were uploaded 
to the RiboGalaxy server where sequences were 
first trimmed to remove adapter sequences. 
Following this ribosomal RNA reads were 
removed from the data and then riboSeqR was 
used via the RiboGalaxy interface to align 
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remaining reads to the human genome 
(GRCh38) before performing differential 
translation analysis (65). A detailed description 
of the workflow and RiboGalaxy parameters 
can be found in Supporting Information Figure 
S1 and Table S4, respectively. 
 
Functional gene characterisation and protein 
networks. 
 Ribosome profiling and proteomic data 
was submitted to the Database for Annotation, 
Visualisation and Integrated Discovery 
(DAVID) online analysis program (Version 6.8, 
https://david.ncifcrf.gov/). Functional and 
physical interactions between proteins were 
discovered using the online STRING Protein-
Protein Interaction Network (https://string-
db.org/) 
 
Data deposition 
The RNA-seq data representing both 
total and ribosome-protected RNA have been 
deposited in ArrayExpress (accession number 
E-MTAB-7466). Both cellular proteomic and 
secretome data have been deposited in PRIDE 
(accession number PXD012985).  
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Figure 1. Ribosome profiling workflow and sequencing data. A) SW1353 workflow: cells were 
treated, for 3 or 24 hours with or without IL-1β. Media was harvested for secretome proteomic analysis 
and cells were harvested for intracellular proteomic analysis after 24h IL-1β exposure. Ribosome 
profiling was performed on cells exposed to IL-1β for 0h and 3h. B) To obtain triplet periodicity of 
ribosome protected fragments, sequencing results (FASTQ files) from amplified libraries were first 
uploaded to RiboGalaxy. The 5’-AGATCGGAAGAGCACACGTCT-3’ adapter sequence and rRNA 
sequences were removed using Cutadapt and Bowtie. Sequences were then aligned to the human 
transcriptome (GRCh38/hg38) using Bowtie prior to riboSeqR analysis. From the riboSeqR analysis, 
triplet periodicity showed that most sequencing reads were 28 nucleotides in length and in frame 1 (red). 
C) RiboGalaxy was next used to perform a metagene analysis of the ribosome density and showed 
similar ribosomal coverage over all transcripts that are 28 nucleotides in length. This representative 
metagene analysis reflects triplet periodicity results in that the majority of 28mer transcripts are in frame 
1 (red). 
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Figure 2. SW1353 transcript/proteomic analyses. A) STRING analysis of the 112 transcripts 
statistically significant differentially translated RPFs from the 3h +/- IL-1β treatment. B) STRING 
analysis of the 200 statistically significant differentially secreted proteins from the 24h +/- IL-1β 
treatment and C) the 41 statistically significant differentially expressed proteins identified in the cell 
layer proteomic analysis. D) Venn diagram showing the relationship of the top 200 transcripts/proteins 
identified through cellular proteomic analysis, ribosome profiling and secretome analysis.  Red circles 
highlight clustering of ribosomal-associated transcripts/proteins and blue circles highlight clustering of 
inflammatory-associated transcripts/proteins. Grey circle highlights interferon-associated proteins. A 
full list of transcripts/proteins and the STRING networks with labels can be found in supplementary 
data tables. 
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Figure 3. Cytokine secretion levels following exposure to IL-1β. A) CCL2 levels in SW1353 medium 
following 24 hour exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. B) CCL2 levels in 
HAC (M70, M76, M86) medium following 24 hour exposure to IL-1β at concentrations ranging from 
0 to 10 ng/ml. C) CCL2 levels in SW1353 medium following 10 ng/ml IL-1β treatment for 0 to 48 
hours. D) CCL2 levels in HAC (M69, F80, F86) medium following 10 ng/ml IL-1β treatment for 0 to 
48 hours. E) IL-6 levels in SW1353 medium following 24 hour exposure to IL-1β at concentrations 
ranging from 0 to 10 ng/ml. F) IL-6 levels in HAC (M70, M76, M86) medium following 24 hour 
exposure to IL-1β at concentrations ranging from 0 to 10 ng/ml. G) IL-6 levels in SW1353 medium 
following 10 ng/ml IL-1β treatment for 0 to 48 hours. H) IL-6 levels in HAC (M69, F80, F86) medium 
following 10 ng/ml IL-1β treatment for 0 to 48 hours. Data was considered significant if p=<0.05 (*) 
and p=<0.01 (**) following Dunnett’s multiple comparison tests.  
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Figure 4. Riboplots of differentially translated mRNA transcripts. Using the Ribo-Seq alignment 
files generated from aligning the sequencing data to the human transcriptome, riboplots were generated 
using the RiboPlot suite on RiboGalaxy for transcripts that were differentially translated between 0h 
and 3h IL-1β exposure. Riboplots show the sub-codon ribosome footprint and the open reading frame 
organisation for both the 0h and 3h time points for A) NFKB1 (NM_003998.3), B) TNFAIP2 
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(NM_006291), C) CCL2 (NM_002982.3), D) CCL7 (NM_006273.3), E) NFKB1Z (NM_031419.3) 
and F) SOX9 (NM_000346.3). Ribo-counts shown for frame 1 (red), Frame 2 (green) and frame 3 
(blue). Total RNA reads in the background (grey) represent the total mRNA for all frames of the 
respective transcript. The black lines  represent the CDS position within the transcript. X-axis represents 
transcript length (in nucleotides) 5’ to 3’. Left y-axis represents the ribo-seq counts for all three reading 
frames (RPFs). Right y-axis represents the RNA-seq counts for total RNA.  
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Figure 5. IL-1β treatment causes an increase in SOD2 mRNA and protein expression in SW1353 
cells. A) Riboplot for SOD2 (NM_000636.3). Ribo-counts shown for frame 1 (red), Frame 2 (green) 
and frame 3 (blue). Total RNA reads in the background (grey) represent the total mRNA for all frames 
of the respective transcript. The black lines represent the CDS position within the transcript. X-axis 
represents transcript length (in nucleotides). Left y-axis represents the ribo-seq counts for all three 
reading frames. Right y-axis represents the RNA-seq counts for total RNA. B) Western blotting for 
SOD2 (22 kDa) in SW1353 intracellular protein lysates treated with 10 ng/ml IL-1β for 0 to 48 hours 
(left-top) and corresponding total protein stain (left-bottom), plus western blotting for SOD2 in SW1353 
intracellular protein lysates treated with 0 to 10 ng/ml IL-1β for 24 hours (right-top) and corresponding 
total protein stain (right-bottom). C) CM-H2DCFDA assay for SW1353 treated with 10 ng/ml IL-1β for 
0 to 48 hours (left) and treated with 0 to 10 ng/ml IL-1β for 24 hours (right). Data variance determined 
by ANOVA p<0.05 (†) or p<0.01 (††). * Significant difference vs. 0 hour treatment time following 
Dunnett’s multiple comparison testing (p<0.05). 
 
